Literature DB >> 16085206

Competence to give informed consent in acute psychosis is associated with symptoms rather than diagnosis.

V Howe1, K Foister, K Jenkins, L Skene, D Copolov, N Keks.   

Abstract

To investigate the association between competence to give informed consent to treatment, specific symptomology and diagnostic category, 110 inpatients diagnosed with DSM-IV acute schizophrenia (n = 64), schizoaffective disorder (n = 25) and bipolar affective disorder (n = 21) were interviewed using the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) and the Positive and Negative Syndrome Scale (PANSS). Results indicated no significant difference in competence between the three disorders. Elevated positive, cognitive and excitement PANSS factor scores had lower MacCAT-T scores. Further analyses indicated symptoms that impair cognition; particularly, conceptual disorganisation and poor attention were most consistently related to poor performance on competence tests.

Entities:  

Mesh:

Year:  2005        PMID: 16085206     DOI: 10.1016/j.schres.2005.03.005

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  9 in total

1.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

2.  Treatment decision-making capacity in non-consensual psychiatric treatment: a multicentre study.

Authors:  G Mandarelli; F Carabellese; G Parmigiani; F Bernardini; L Pauselli; R Quartesan; R Catanesi; S Ferracuti
Journal:  Epidemiol Psychiatr Sci       Date:  2017-03-09       Impact factor: 6.892

3.  The capacity of schizophrenia and bipolar disorder individuals to make autonomous decisions about pharmacological treatments for their illness in real life: A scoping review.

Authors:  Enric Vincens Pons; Luis Salvador-Carulla; Alfredo Calcedo-Barba; Silvia Paz; Thomas Messer; Bruno Paccardi; Scott L Zeller
Journal:  Health Sci Rep       Date:  2020-08-09

4.  Participants with schizophrenia retain the information necessary for informed consent during clinical trials.

Authors:  Bernard A Fischer; Robert P McMahon; Walter A Meyer; Daniel J Slack; Paul S Appelbaum; William T Carpenter
Journal:  J Clin Psychiatry       Date:  2013-06       Impact factor: 4.384

Review 5.  Testing decision-making competency of schizophrenia participants in clinical trials. A meta-analysis and meta-regression.

Authors:  Sorin Hostiuc; Mugurel Constantin Rusu; Ionut Negoi; Eduard Drima
Journal:  BMC Psychiatry       Date:  2018-01-05       Impact factor: 3.630

6.  The recovery of factors associated with decision-making capacity in individuals with psychosis.

Authors:  Colin Fernandez; Harry G Kennedy; Miriam Kennedy
Journal:  BJPsych Open       Date:  2017-05-04

Review 7.  Informed Consent Decision-Making in Deep Brain Stimulation.

Authors:  Gabriele Mandarelli; Germana Moretti; Massimo Pasquini; Giuseppe Nicolò; Stefano Ferracuti
Journal:  Brain Sci       Date:  2018-05-11

8.  Translating clinical findings to the legal norm: the Defendant's Insanity Assessment Support Scale (DIASS).

Authors:  Giovanna Parmigiani; Gabriele Mandarelli; Gerben Meynen; Felice Carabellese; Stefano Ferracuti
Journal:  Transl Psychiatry       Date:  2019-11-07       Impact factor: 6.222

9.  Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer's Disease.

Authors:  Elodie Bertrand; Eelco van Duinkerken; J Landeira-Fernandez; Marcia C N Dourado; Raquel L Santos; Jerson Laks; Daniel C Mograbi
Journal:  Front Aging Neurosci       Date:  2017-06-16       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.